Evidence map›Paper›PMID 39179932›Full record

ArticleNature immunology2024

Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development.

Anna S Fedl, Hiromi Tagoh, Sarah Gruenbacher, Qiong Sun, Robyn L Schenk, Kimon Froussios, Markus Jaritz, Meinrad Busslinger, Tanja A Schwickert

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. PAX Family, Master Regulator in Cancer.Diagnostics (Basel, Switzerland) · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Anna S Fedl *Research Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.
Hiromi Tagoh *Research Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.ORCID http://orcid.org/0000-0001-9905-6992
Sarah Gruenbacher *Research Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.ORCID http://orcid.org/0000-0002-6691-0766
Qiong SunResearch Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.
Robyn L SchenkResearch Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.
Kimon FroussiosResearch Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.
Markus JaritzResearch Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.ORCID http://orcid.org/0000-0002-9326-2047
Meinrad BusslingerResearch Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria. meinrad.busslinger@imp.ac.at.ORCID http://orcid.org/0000-0002-9111-9351
Tanja A SchwickertResearch Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria. tanja.schwickert@imp.ac.at.ORCID http://orcid.org/0000-0002-3371-2376

Funding

Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) P34372Austrian Science Fund FWF P 34372EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 740349
6 · The paper itself

Abstract

Early B cell lymphopoiesis depends on E2A, Ebf1, Pax5 and Ikaros family members. In the present study, we used acute protein degradation in mice to identify direct target genes of these transcription factors in pro-B, small pre-B and immature B cells. E2A, Ebf1 and Pax5 predominantly function as transcriptional activators by inducing open chromatin at their target genes, have largely unique functions and are essential for early B cell maintenance. Ikaros and Aiolos act as dedicated repressors to cooperatively control early B cell development. The surrogate light-chain genes Igll1 and Vpreb1 are directly activated by Ebf1 and Pax5 in pro-B cells and directly repressed by Ikaros and Aiolos in small pre-B cells. Pax5 and E2A contribute to V(D)J recombination by activating Rag1, Rag2, Dntt, Irf4 and Irf8. Similar to Pax5, Ebf1 also represses the cohesin-release factor gene Wapl to mediate prolonged loop extrusion across the Igh locus. In summary, in vivo protein degradation has provided unprecedented insight into the control of early B cell lymphopoiesis by five transcription factors.

Indexed as

Basic Helix-Loop-Helix ProteinsB-LymphocytesIkaros Transcription FactorLymphopoiesisPAX5 Transcription FactorTrans-ActivatorsAnimalsCell DifferentiationImmunoglobulin Light Chains, SurrogateInterferon Regulatory FactorsMiceMice, Inbred C57BLMice, KnockoutPrecursor Cells, B-LymphoidProteolysisTranscription Factor 3Basic Helix-Loop-Helix ProteinsEbf1 protein, mouseIkaros Transcription FactorIkzf3 protein, mouseImmunoglobulin Light Chains, SurrogateInterferon Regulatory FactorsPax5 protein, mousePAX5 Transcription FactorTcf12 protein, mouseTcf3 protein, mouseTcf7l1 protein, mouseTrans-ActivatorsTranscription Factor 3Transcription Factor 7-Like 1 ProteinZfpn1a1 protein, mouse

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.